-

Lunaphore Webinar to highlight real-world implementation of COMET™ at SciLifeLab

LAUSANNE, Switzerland--(BUSINESS WIRE)--Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it will host a virtual scientific talk in partnership with Labroots on October 21, 2021, about spatial “omics” methods as a laboratory service. Dr. Charlotte Stadler, Head of the National Spatial Proteomics Facility and platform coordination officer for the Spatial and Single Cell Biology Platform at SciLifeLab, a world-renowned institute in Sweden focused on the advancement of molecular biosciences, will discuss the incorporation of spatial proteomics technologies in service laboratory workflows. The talk will focus on how her facility is utilizing COMET™, Lunaphore’s all-in-one staining and imaging platform for high-throughput, hyperplex immunofluorescence, to explore the cellular landscape across several tissue types.

In the webinar, Dr. Stadler will discuss multiplexed spatial proteomics using sequential immunofluorescence and show results obtained with COMET™. The Spatial and Single Cell Biology (SSCB) platform at SciLifeLab expects to fully integrate COMET™ into its workflow and offer it as a service next year.

“The COMET™ system allows for systematic development of multiplexed panels for a variety of tissues,” said Dr. Stadler. “Using sequential indirect immunofluorescence, one’s existing set of validated primary antibodies can be optimized and used in a multiplexed manner.”

“Our work with SciLifeLab to integrate COMET™ into their service laboratory workflows is a key step in our mission to bring spatial biology into every laboratory,” said Déborah Heintze, Co-Founder and Chief Marketing Officer at Lunaphore. “We are excited to work with Dr. Stadler and her team as they implement COMET™ for large-scale use.”

Learn more about the event and register here.

PRESENTATION DETAILS

Including Spatial Proteomics in your research - why and how
Date and time: Thursday, October 21, 2021; 4:00 pm CEST / 7:00 am PT / 10:00 am ET
Speaker: Dr. Charlotte Stadler, Head of the National Spatial Proteomics Facility (Stockholm, Sweden)

About Lunaphore

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com.

Contacts

For further information contact:
Irene Tamayo
Lunaphore Corporate Communications
Email: communications@lunaphore.com

Lunaphore Technologies SA

Details
Headquarters: Lausanne, Switzerland
CEO: Ata Tuna Ciftlik
Employees: 38
Organization: PRI

Release Versions

Contacts

For further information contact:
Irene Tamayo
Lunaphore Corporate Communications
Email: communications@lunaphore.com

Social Media Profiles
More News From Lunaphore Technologies SA

Lunaphore to Get Acquired by Bio-Techne

TOLOCHENAZ, Switzerland & MINNEAPOLIS--(BUSINESS WIRE)--Lunaphore Technologies SA, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3. Founded in 2014 and headquartered i...

Lunaphore and CST Partnership Advances Spatial Biology Research with Over 1,700 IHC-Validated Antibodies for Use on COMET™

LAUSANNE, Switzerland & DANVERS, Mass.--(BUSINESS WIRE)--Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership to enable the use of CST® antibodies on the Lunaphore COMET™ platform, a scalable hyperplex imaging solution for fully automated spatial biology. CST is a trusted pr...

Lunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET™, Combining Power of Trusted Antibody Provider With Superior Multiplex Capabilities

LAUSANNE, Switzerland & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and abcam (NASDAQ: ABCM), a global life science company working together with researchers to advance science and enable faster breakthroughs, today announced an agreement to co-market abcam primary antibodies specifically validated for use on Lunaphore’s COMET™ platform. The agreement will enable researchers to use abca...
Back to Newsroom